Immunogenicity studies with a genetically engineered hexavalent porA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys

Rouppe van_der Voort, ESchuller, MHolst, Jde Vries, Pvan der Ley, Privmvan den Dobbelsteen, GrivmPoolman, J2025-03-172025-03-172000https://rivm.openrepository.com/handle/10029/638433Immunogenicity studies with a genetically engineered hexavalent porA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeysArticleVaccine 2000; 18:1334-432025-03-17